Associated Papers
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.
Gruber JJ et al.
Nature Cancer, 2022
36253484 (PubMed )
Supplement: 43018_2022_439_MOESM6_ESM.xlsx › Fig._4A
Select a paper to view details